187 related articles for article (PubMed ID: 23229866)
1. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.
Castellsague J; Pisa F; Rosolen V; Drigo D; Riera-Guardia N; Giangreco M; Clagnan E; Tosolini F; Zanier L; Barbone F; Perez-Gutthann S
Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):365-75. PubMed ID: 23229866
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy.
Pisa F; Castellsague J; Drigo D; Riera-Guardia N; Giangreco M; Rosolen V; Clagnan E; Zanier L; Perez-Gutthann S; Barbone F
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1195-204. PubMed ID: 23959537
[TBL] [Abstract][Full Text] [Related]
3. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
[TBL] [Abstract][Full Text] [Related]
4. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan.
Chang CH; Chen HC; Lin JW; Kuo CW; Shau WY; Lai MS
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):763-71. PubMed ID: 21618340
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
6. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).
Castellsague J; Riera-Guardia N; Calingaert B; Varas-Lorenzo C; Fourrier-Reglat A; Nicotra F; Sturkenboom M; Perez-Gutthann S;
Drug Saf; 2012 Dec; 35(12):1127-46. PubMed ID: 23137151
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
[TBL] [Abstract][Full Text] [Related]
14. Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study.
Lafrance JP; Miller DR
Am J Kidney Dis; 2012 Jul; 60(1):82-9. PubMed ID: 22503390
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
16. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
17. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
[TBL] [Abstract][Full Text] [Related]
18. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
[TBL] [Abstract][Full Text] [Related]
19. Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: a class effect?
Hudson M; Rahme E; Richard H; Pilote L
Arthritis Rheum; 2007 Apr; 57(3):516-23. PubMed ID: 17394181
[TBL] [Abstract][Full Text] [Related]
20. Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.
Masclee GMC; Straatman H; Arfè A; Castellsague J; Garbe E; Herings R; Kollhorst B; Lucchi S; Perez-Gutthann S; Romio S; Schade R; Schink T; Schuemie MJ; Scotti L; Varas-Lorenzo C; Valkhoff VE; Villa M; Sturkenboom MCJM
PLoS One; 2018; 13(11):e0204746. PubMed ID: 30383755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
